GSE165548 gemcitabine 2 v 8 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE165548_gemcitabine_2_v_8_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE165548_gemcitabine_2_v_8_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE165548_gemcitabine_2_v_8_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE165548_gemcitabine_2_v_8_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

mitochondrial ribosomal protein S18B

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 5

Gene

H3.3 histone A

Gene

differentiation antagonizing non-protein coding RNA

Gene

small nucleolar RNA host gene 16

Gene

HOXA transcript antisense RNA, myeloid-specific 1

Gene

GABPB1 intronic transcript

Gene

hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA

Gene

PRR34 antisense RNA 1

  • Gene

    mitochondrial ribosomal protein S18B



  • Gene

    small nucleolar RNA host gene 5



  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    HOXA transcript antisense RNA, myeloid-specific 1


  • Gene

    GABPB1 intronic transcript


  • Gene

    hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA


  • Gene

    PRR34 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.